Cipla

{
  "main_header": {
    "sid": 597145,
    "name": "Cipla",
    "stock_name": "Cipla",
    "full_name": "Cipla Ltd.",
    "name_url": "stocks-analysis/cipla",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,440.10",
    "chg": 2.2,
    "chgp": "0.15%",
    "dir": 1,
    "prev_price": "1,437.90",
    "mcapval": "116,297.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 500087,
    "symbol": "CIPLA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE059A01026",
    "curr_date": "Jun 25, 03:30 PM",
    "curr_time": "14:50 PM",
    "last_traded_at": "Jun 25, 03:30 PM IST",
    "bse_nse_vol": "12.73 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 25, 2026",
    "traded_date_str": "2026 06 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cipla-597145-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "P/E at 28.41 vs Industry's 34.66: What the Data Shows for Cipla Ltd.",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-navigating-nifty-50-membership-amid-institutional-shifts-and-sector-dynamics-4072695",
        "imagepath": "",
        "date": "2026-06-25 09:21:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Discount to Industry Average</strong></p>\n                <p>The current P/E ratio of 28.41 for <a href=\"https://www.marketsmojo.com/stocks-analysis/cipla-597145-0\" class=\"stk\">Cipla Ltd.</a> represents a discount of approximately 18% relative to the sector average of 34.66. This valuation gap suggests that the market is pricing in either a more cautious outlook on Cipla’s earnings growth or perceives higher risks compared to its peers. Given the company’s large-cap status with a market capitalisation of ₹1,16,116 crores, this discount is particularly notable. It may reflect concerns over competitive pressures or regulatory challenges within the pharmaceutical space. However, the valuation also implies a potential margin of safety for investors relative to t..."
      },
      {
        "title": "Cipla Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4069590",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CiplaLtd_technicaldot_4069590.png",
        "date": "2026-06-24 08:02:35",
        "description": "Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent upgrade in weekly MACD and bullish monthly RSI readings, the stock faces mixed signals from other technical indicators, reflecting a complex market sentiment as it trades near ₹1,433.10, up 1.26% on 24 Jun 2026."
      },
      {
        "title": "Cipla Ltd. Rallies 3.12% and Holds Above All Major Moving Averages — Momentum Gains Strength",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-hits-intraday-high-with-strong-312-surge-on-23-jun-2026-4069129",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CiplaLtd_priceRelatedfactors_4069129.png",
        "date": "2026-06-23 11:16:15",
        "description": "The Sensex edged up 0.07% on 23 Jun 2026, while Cipla Ltd. surged 3.12%, outperforming its sector by 1.37 percentage points. This strong single-session gain stands out as a clear stock-specific event amid a broadly steady market environment."
      },
      {
        "title": "Rs 1,450 Calls on Cipla Ltd. See Heavy Activity — What the Strike Price Tells You",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-sees-surge-in-call-option-activity-amid-bullish-market-momentum-4069099",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CiplaLtd_most_active_stocks_calls_4069099.png",
        "date": "2026-06-23 11:00:08",
        "description": "11,852 call contracts at the Rs 1,450 strike traded on Cipla Ltd. on 23 Jun 2026, with the stock closing at Rs 1,443.50 after a 2.59% gain. This near at-the-money activity, combined with strong price momentum, suggests a focused directional bet as expiry approaches."
      },
      {
        "title": "Cipla Ltd. Sees Robust Trading Activity Amid Upgraded Sell Rating",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-sees-robust-trading-activity-amid-upgraded-sell-rating-4069119",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CiplaLtd_most_active_equities_by_value_4069119.png",
        "date": "2026-06-23 11:00:07",
        "description": "Cipla Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 23 June 2026. The stock demonstrated strong price momentum, buoyed by significant institutional participation and an upgrade in its Mojo Grade from Hold to Sell, signalling a cautious outlook despite recent gains."
      },
      {
        "title": "2548 Put Contracts on Cipla Ltd. at Rs 1400 Strike Ahead of 30 June Expiry",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-sees-heavy-put-option-activity-amid-bearish-sentiment-4068742",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CiplaLtd_most_active_stocks_puts_4068742.png",
        "date": "2026-06-23 10:00:10",
        "description": "Rs 1400 put options on Cipla Ltd. attracted 2,548 contracts on 23 Jun 2026, with the stock trading at Rs 1,436. This 2.5% out-of-the-money strike, combined with a rising share price and strong open interest, suggests the put activity is more likely protective hedging than outright bearish positioning."
      },
      {
        "title": "P/E at 27.97 vs Industry's 34.38: What the Data Shows for Cipla Ltd.",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-navigating-nifty-50-membership-amid-institutional-shifts-and-market-dynamics-4068533",
        "imagepath": "",
        "date": "2026-06-23 09:20:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Discount Amidst Sector Premiums</strong></p>\n                <p><a href=\"https://www.marketsmojo.com/stocks-analysis/cipla-597145-0\" class=\"stk\">Cipla Ltd.</a> trades at a P/E multiple of 27.97, which is approximately 18.7% below the Pharmaceuticals & Biotechnology industry average of 34.38. This discount suggests that the market is pricing in either a more cautious outlook on Cipla’s earnings growth or perceives higher risks relative to its peers. The sector itself commands a premium valuation, reflecting robust earnings growth expectations and defensive qualities amid market volatility. The divergence between Cipla’s valuation and the sector average raises the question <a href=\"https://www.marketsmojo.com/stocks-analysis/cipla-597145-0\" class=\"ctx\">what is..."
      },
      {
        "title": "Rs 1,400 Puts — 1.04% Below Current Price — Draw 8,991 Contracts on Cipla Ltd.",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-sees-surge-in-put-option-activity-amid-bearish-sentiment-4067586",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CiplaLtd_most_active_stocks_puts_4067586.png",
        "date": "2026-06-22 14:00:06",
        "description": "Rs 1,400 put options on Cipla Ltd. attracted 8,991 contracts on 22 Jun 2026, signalling notable activity just below the current stock price of Rs 1,414.7. This surge in put trading comes as the stock outperformed its sector by 3.87% and rose 4.56% on the day, raising questions about whether the options activity reflects hedging, bearish bets, or put writing strategies."
      },
      {
        "title": "Cipla Ltd Sees Sharp Open Interest Surge Amid Bullish Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-sees-sharp-open-interest-surge-amid-bullish-market-momentum-4067541",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CiplaLtd_oi_spurts_by_underlying_4067541.png",
        "date": "2026-06-22 13:00:06",
        "description": "Cipla Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment on 22 June 2026. The stock outperformed its sector peers and broader market indices, signalling increased investor interest and potential directional bets in the near term."
      }
    ],
    "total": 1094,
    "sid": "597145",
    "stock_news_url": "https://www.marketsmojo.com/news/cipla-597145"
  },
  "announcements": [
    {
      "details": "Cipla Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Cipla Limited has informed the Exchange that its wholly owned subsidiary Cipla (EU) Limited, holding 60% stake in Cipla Pharma Lanka (Private) Limited {Cipla Pharma Lanka), Sri Lanka, has signed an agreement with CitiHealth Imports",
      "source": "NSE",
      "caption": "Cipla Limited - Acquisition",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Cipla Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "21-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "23 Jul 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has declared <strong>650%</strong> dividend, ex-date: 05 Jun 26",
          "dt": "2026-06-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has announced <strong>3:2</strong> bonus issue, ex-date: 24 Apr 06",
          "dt": "2006-04-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

P/E at 28.41 vs Industry's 34.66: What the Data Shows for Cipla Ltd.

2026-06-25 09:21:04

Valuation Picture: Discount to Industry Average

The current P/E ratio of 28.41 for Cipla Ltd. represents a discount of approximately 18% relative to the sector average of 34.66. This valuation gap suggests that the market is pricing in either a more cautious outlook on Cipla’s earnings growth or perceives higher risks compared to its peers. Given the company’s large-cap status with a market capitalisation of ₹1,16,116 crores, this discount is particularly notable. It may reflect concerns over competitive pressures or regulatory challenges within the pharmaceutical space. However, the valuation also implies a potential margin of safety for investors relative to t...

Read full news article

Cipla Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-24 08:02:35

Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent upgrade in weekly MACD and bullish monthly RSI readings, the stock faces mixed signals from other technical indicators, reflecting a complex market sentiment as it trades near ₹1,433.10, up 1.26% on 24 Jun 2026.

Read full news article

Cipla Ltd. Rallies 3.12% and Holds Above All Major Moving Averages — Momentum Gains Strength

2026-06-23 11:16:15

The Sensex edged up 0.07% on 23 Jun 2026, while Cipla Ltd. surged 3.12%, outperforming its sector by 1.37 percentage points. This strong single-session gain stands out as a clear stock-specific event amid a broadly steady market environment.

Read full news article

Rs 1,450 Calls on Cipla Ltd. See Heavy Activity — What the Strike Price Tells You

2026-06-23 11:00:08

11,852 call contracts at the Rs 1,450 strike traded on Cipla Ltd. on 23 Jun 2026, with the stock closing at Rs 1,443.50 after a 2.59% gain. This near at-the-money activity, combined with strong price momentum, suggests a focused directional bet as expiry approaches.

Read full news article

Cipla Ltd. Sees Robust Trading Activity Amid Upgraded Sell Rating

2026-06-23 11:00:07

Cipla Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 23 June 2026. The stock demonstrated strong price momentum, buoyed by significant institutional participation and an upgrade in its Mojo Grade from Hold to Sell, signalling a cautious outlook despite recent gains.

Read full news article

2548 Put Contracts on Cipla Ltd. at Rs 1400 Strike Ahead of 30 June Expiry

2026-06-23 10:00:10

Rs 1400 put options on Cipla Ltd. attracted 2,548 contracts on 23 Jun 2026, with the stock trading at Rs 1,436. This 2.5% out-of-the-money strike, combined with a rising share price and strong open interest, suggests the put activity is more likely protective hedging than outright bearish positioning.

Read full news article

P/E at 27.97 vs Industry's 34.38: What the Data Shows for Cipla Ltd.

2026-06-23 09:20:51

Valuation Picture: Discount Amidst Sector Premiums

Cipla Ltd. trades at a P/E multiple of 27.97, which is approximately 18.7% below the Pharmaceuticals & Biotechnology industry average of 34.38. This discount suggests that the market is pricing in either a more cautious outlook on Cipla’s earnings growth or perceives higher risks relative to its peers. The sector itself commands a premium valuation, reflecting robust earnings growth expectations and defensive qualities amid market volatility. The divergence between Cipla’s valuation and the sector average raises the question what is...

Read full news article

Rs 1,400 Puts — 1.04% Below Current Price — Draw 8,991 Contracts on Cipla Ltd.

2026-06-22 14:00:06

Rs 1,400 put options on Cipla Ltd. attracted 8,991 contracts on 22 Jun 2026, signalling notable activity just below the current stock price of Rs 1,414.7. This surge in put trading comes as the stock outperformed its sector by 3.87% and rose 4.56% on the day, raising questions about whether the options activity reflects hedging, bearish bets, or put writing strategies.

Read full news article

Cipla Ltd Sees Sharp Open Interest Surge Amid Bullish Market Momentum

2026-06-22 13:00:06

Cipla Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment on 22 June 2026. The stock outperformed its sector peers and broader market indices, signalling increased investor interest and potential directional bets in the near term.

Read full news article

View All News